Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T14:32:13.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now presents a 403 Forbidden error page, with minimal site chrome showing '403' and basic header/footer. This replaces the previous study content with an access-denied notice.
    Difference
    22%
    Check dated 2026-09-20T19:46:41.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This is a minor system update with no changes to visible content.
    Difference
    0.0%
    Check dated 2026-08-30T07:01:24.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study status was updated to Terminated due to no drug supply, with results posted. New data-sharing plans and updated study documents (Informed Consent Form and Protocol) were added.
    Difference
    9%
    Check dated 2026-08-23T04:01:10.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.4 to v3.6.5, reflecting a new version of the page. This is a metadata update and does not alter the study content.
    Difference
    0.1%
    Check dated 2026-08-08T22:44:49.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces the previous v3.6.3. This signals a minor platform update that does not modify the study information displayed on the page.
    Difference
    0.1%
    Check dated 2026-07-25T12:37:05.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.